Live from the NIH registry
Studies recruiting near San Bernardino right now
Top 25 of 460 recruiting studies, sorted by proximity — each links to its official registry page
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Loma Linda University Medical Center — Loma Linda, California (6.7 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
Velocity Clinical Research - San Bernardino — San Bernardino, California (2.3 mi)
· Sponsor: Crystalys Therapeutics
Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN)
Primary Membranous Nephropathy
Phase 2
Interventional 30 participants sought
Research Site — Loma Linda, California (6.7 mi)
· Sponsor: Alexion Pharmaceuticals, Inc.
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Loma Linda University Medical Center — Loma Linda, California (6.7 mi)
· Sponsor: Medtronic MiniMed, Inc.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Loma Linda University Medical Center — Loma Linda, California (6.7 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis
Phase 2
Interventional 168 participants sought
North America Research Institute — San Dimas, California (29.4 mi)
· Sponsor: R1 Therapeutics
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Riverside Community Hospital — Riverside, California (14.3 mi)
· Sponsor: Duke University
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Kaiser Permanente-Fontana — Fontana, California (8.7 mi)
· Sponsor: NRG Oncology
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Intracerebral Hemorrhage
Phase 3
Interventional 350 participants sought
Kaiser Permanente Fontana Medical Center — Fontana, California (8.7 mi)
· Sponsor: Joseph Broderick, MD
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
Malignant Glioma
Phase 1, Phase 2
Interventional 132 participants sought
Loma Linda University Medical Center — Loma Linda, California (6.7 mi)
· Sponsor: National Cancer Institute (NCI)
Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients
Irritability Associated With Autism Spectrum Disorder
Phase 3
Interventional 160 participants sought
Inland Psychiatric Medical Group Inc — Redlands, California (8.7 mi)
· Sponsor: Intra-Cellular Therapies, Inc.
Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy
IgA Nephropathy
Phase 4
Interventional 60 participants sought
Loma Linda University — San Bernardino, California (2.3 mi)
· Sponsor: Calliditas Therapeutics AB
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic Targets
Type 2 Diabetes
Phase 2
Interventional 60 participants sought
Catalina Research Institute, LLC — Montclair, California (23.1 mi)
· Sponsor: Biomea Fusion Inc.
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
Asthma
Phase 3
Interventional 440 participants sought
Research Site — Riverside, California (14.3 mi)
· Sponsor: AstraZeneca
Wound Irrigation With Saline Versus Hypodilute-chlorhexidine After Cesarean Section (WISHES Study)
Cesarean Section Complications, Cesarean Section; Infection
N/A
Interventional 400 participants sought
Loma Linda University — Loma Linda, California (6.7 mi)
· Sponsor: Loma Linda University
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Atopic Dermatitis
N/A
Observational 1,000 participants sought
Galderma Investigational Site - 7074 — Corona, California (24.1 mi)
· Sponsor: Galderma R&D
Efficacy of Preoperative Administration of Gabapentin in 3rd Molar Dental Extraction.
Dental Pain and Sensation Disorder, Pain, Postoperative
Phase 4
Interventional 98 participants sought
Loma Linda University Health — Loma Linda, California (6.7 mi)
· Sponsor: Loma Linda University
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Bipolar Disorder Type I With Mania
Phase 3
Interventional 450 participants sought
Clinical Innovations, Inc. dba CITrials — Riverside, California (14.3 mi)
· Sponsor: Bristol-Myers Squibb
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
Healthy
Phase 3
Interventional 6,000 participants sought
Loma Linda University Children's Hospital — Loma Linda, California (6.7 mi)
· Sponsor: Pfizer
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
Loma Linda University Medical Center — Loma Linda, California (6.7 mi)
· Sponsor: National Cancer Institute (NCI)
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Ganglioneuroblastoma, Nodular, Neuroblastoma
Phase 3
Interventional 478 participants sought
Loma Linda University Medical Center — Loma Linda, California (6.7 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis, Ulcerative Colitis Chronic
Phase 2
Interventional 143 participants sought
Prospective Research Innovations — Rancho Cucamonga, California (17.3 mi)
· Sponsor: Eli Lilly and Company
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
Menstrual Migraine
Phase 3
Interventional 723 participants sought
Axiom Research — Colton, California (4.8 mi)
· Sponsor: Pfizer
Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
Schizophrenia
Phase 3
Interventional 690 participants sought
Reviva site — Riverside, California (14.3 mi)
· Sponsor: Reviva Pharmaceuticals
Digital Health Intervention for Children With ADHD
ADHD
N/A
Interventional 60 participants sought
UCR Psychiatry at Grindstaff Community School — Riverside, California (14.3 mi)
· Sponsor: University of California, Riverside